NR3C1 and breast neoplasm: With regard to clinical relevance, we identified a pS134-GR 24-gene signature induced by TGFβ1 that may serve as a valuable paired diagnostic with which to identify patients who have GR-driven breast tumors and are thus at high risk of succumbing to metastatic disease.